Author

Iker Huerga

Observed names: Huerga, Iker, I. Huerga, Iker Huerga Sanchez

Observed institutions: Memorial Sloan Kettering Cancer Center, Mondragon Unibertsitatea, Tempus Labs (United States)

OpenAlex ID: A5046875593

OncoTree: A Cancer Classification System for Precision Oncology

2021 · Ritika Kundra, Hongxin Zhang, et al. · JCO Clinical Cancer Informatics · 147

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

2024 · Rei Kudo, Anton Safonov, et al. · Cancer Cell · 57

Semantically Enabling Pharmacogenomic Data for the Realization of Personalized Medicine

2012 · Matthias Samwald, Adrien Coulet, et al. · Pharmacogenomics · 20

Supporting clinical processes with semantic web technologies: a case in breast cancer treatment

2010 · Ainhoa Serna Nocedal, Jon Kepa Gerrikagoitia, et al. · International Journal of Metadata Semantics and Ontologies · 9

Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status—A Real-World Analysis in Patients With Advanced NSCLC

2025 · David J. Cantor, Halla Nimeiri, et al. · Clinical Lung Cancer · 5

Real-world outcome analysis of patients with advanced gastric and gastroesophageal adenocarcinoma with HER2-low expression treated with first-line therapy.

2023 · Mary Frances Mulcahy, Halla Nimeiri, et al. · Journal of Clinical Oncology · 4

1403 Outcomes following first-line immunotherapy with or without chemotherapy stratified by KRAS mutational status – A real world analysis in patients with advanced NSCLC

2022 · Charu Aggarwal, Halla Nimeiri, et al. · Journal for ImmunoTherapy of Cancer · 1

Introduction to NIPS 2017 Competition Track

2018 · Sergio Escalera, Markus Weimer, et al. · The Springer series on challenges in machine learning · 1

Fundamentals of Semantic Web Technologies in Medical Environments: a case in breast cancer risk estimation

2010 · Huerga, Iker, Serna, Ainhoa, et al. · arXiv (Cornell University) · 1

Abstract 1467: Mechanism-aware cancer therapy planning with group-relative policy optimization on a multimodal oncology foundation model.

2026 · Eric E. Schadt, Jackson Stokes, et al. · Cancer Research

Abstract 6882: Mechanism-concordant cell-line selection: Bridging real-world tumor drivers and in vitro models for target validation.

2026 · Aviva G. Beckmann, Phillip Comella, et al. · Cancer Research

EPID-23. Patterns of care and clinical outcomes of patients with IDH -mutant high-grade glioma in the United States from 2014-2023: a real-world analysis of the Tempus Lens database

2025 · John Li, Michael L Maitland, et al. · Neuro-Oncology

EP.07D.05 Molecular Testing Care Gap Analysis of EGFR Mutation for Early-Stage NSCLC Patients in Community Practices

2024 · J. Dow, N. Zimmerman, et al. · Journal of Thoracic Oncology

Abstract 225: Integration of patient-derived tumor organoids and patient clinical multimodal data to investigate the role of organoids in predicting treatment response

2024 · Kathleen A. Burke, Brian Larsen, et al. · Cancer Research

Real-world outcomes of first-line immune checkpoint inhibitors with or without chemotherapy in KRAS G12C altered NSCLC according to PD-L1 status.

2023 · Charu Aggarwal, Lamisa Parkar, et al. · Journal of Clinical Oncology

Linked Data implications for authority control and vocabularies. An STM Perspective

2016 · Iker Huerga · Dialnet (Universidad de la Rioja)

Works count: 16

Citation count: 245

H-index: 5

I10-index: 3